Cell Fate Decisions
β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1
Sazzad Hassan, Ashok Pullikuth, Kyle C. Nelson, Anabel Flores, Yelena Karpova, Daniele Baiz, Sinan Zhu, Guangchao Sui, Yue Huang, Young A. Choi, Ralph D'Agostino Jr, Ashok Hemal, Urs von Holzen, Waldemar Debinski and George Kulik
Sazzad Hassan
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
2Indiana University School of Medicine-South Bend, South Bend, Indiana.
Ashok Pullikuth
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Kyle C. Nelson
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Anabel Flores
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Yelena Karpova
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Daniele Baiz
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Sinan Zhu
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Guangchao Sui
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Yue Huang
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Young A. Choi
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Ralph D'Agostino Jr
3Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Ashok Hemal
4Department of Urology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Urs von Holzen
2Indiana University School of Medicine-South Bend, South Bend, Indiana.
5Goshen Center for Cancer Care, Goshen, Indiana.
Waldemar Debinski
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
3Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, North Carolina.
6Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, North Carolina.
George Kulik
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
3Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, North Carolina.
4Department of Urology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
7Department of Life Sciences, Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
DOI: 10.1158/1541-7786.MCR-19-1037 Published December 2020

This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
December 2020
Volume 18, Issue 12
Volume 18, Issue 12
β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1
Sazzad Hassan, Ashok Pullikuth, Kyle C. Nelson, Anabel Flores, Yelena Karpova, Daniele Baiz, Sinan Zhu, Guangchao Sui, Yue Huang, Young A. Choi, Ralph D'Agostino Jr, Ashok Hemal, Urs von Holzen, Waldemar Debinski and George Kulik
Mol Cancer Res December 1 2020 (18) (12) 1839-1848; DOI: 10.1158/1541-7786.MCR-19-1037
β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1
Sazzad Hassan, Ashok Pullikuth, Kyle C. Nelson, Anabel Flores, Yelena Karpova, Daniele Baiz, Sinan Zhu, Guangchao Sui, Yue Huang, Young A. Choi, Ralph D'Agostino Jr, Ashok Hemal, Urs von Holzen, Waldemar Debinski and George Kulik
Mol Cancer Res December 1 2020 (18) (12) 1839-1848; DOI: 10.1158/1541-7786.MCR-19-1037
Jump to section
Advertisement